Area of research
Oncology · Molecular Biology
Research interest
Research focused on Multiple drug resistance and Pharmacology, with related work in Abcg2, ATP-binding cassette transporter, ABCC1. Notable publications include 'Gold nanoparticles: synthesis, physiochemical properties and therapeutic applications in cancer', 'Paclitaxel resistance related to nuclear envelope structural sturdiness', and 'Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression'.
Innovative and environmentally friendly MICP surface curing: Enhancing mechanical and durability properties of concrete
ABCB1-dependent collateral sensitivity of multidrug-resistant colorectal cancer cells to the survivin inhibitor MX106-4C
Overexpression of ABCC1 and ABCG2 confers resistance to talazoparib, a poly (ADP-Ribose) polymerase inhibitor
Paclitaxel resistance related to nuclear envelope structural sturdiness
Gold nanoparticles: synthesis, physiochemical properties and therapeutic applications in cancer
Overexpression of ABCC1 Confers Drug Resistance to Betulin
Overexpression of ABCG2 Confers Resistance to MLN7243, a Ubiquitin-Activating Enzyme (UAE) Inhibitor
Natural Product as Substrates of ABC Transporters: A Review
Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells
Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells
NVP-CGM097, an HDM2 Inhibitor, Antagonizes ATP-Binding Cassette Subfamily B Member 1-Mediated Drug Resistance
Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression
Derivative of 5-cyano-6-phenylpyrimidin antagonizes ABCB1- and ABCG2-mediated multidrug resistance